NCT06533657 2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Completed
ZYUS Life Sciences Inc.
British Columbia Cancer Agency
Arbeitsgemeinschaft medikamentoese Tumortherapie
Jazz Pharmaceuticals
University of Arizona
M.D. Anderson Cancer Center
Duke University
AHS Cancer Control Alberta